Singularity Hub reviews 100+
Aaron Saenz at Singularity Hub writes a thoughtful review of 100+: What would you do with another 75 years on this Earth? Not as a pain wracked wizened elder in a nursing home, but as a vibrant super-centenarian with the
Technology & Society
Aaron Saenz at Singularity Hub writes a thoughtful review of 100+: What would you do with another 75 years on this Earth? Not as a pain wracked wizened elder in a nursing home, but as a vibrant super-centenarian with the
This is an excellent article from the NYT about how gene therapy has been used to kill cancer. Dr. Carl June at U Penn is really a leader in this field.
I spoke at the Economist’s Human Potential conference yesterday and Andrew Nusca from SmartPlanet.com wrote an excellent blog summary about it today.
Here’s my interview with Glenn Reynolds on his InstaVision show. Internet TV is really taking off, and Glenn’s show is one of the best political/topic-based ones out there.
100 Plus is on the Washington Post’s bestseller list this week (#8)! Very exciting! Hopefully, the more people who read the book, the more we will all realize the importance of research on biological aging and human repair.
Nick Schulz reviewed 100 Plus in the WSJ today. He says that the book “entertainingly chronicles efforts to conquer aging and death from antiquity to today.” Read the whole review here.
The Wall Street Journal published an excerpt of 100 Plus today, accompanied by a video (embedded below). Reading it is a good way to discover if you’ll like the entire book.
Below are the blurbs from the back cover of the book and here is a link to Amazon.com where you can see reviews from others who have read 100 Plus. “At a time when companies think only of quarterly results
Here’s a video about my new book, 100 Plus:
Researchers funded by the UK-based Biotechnology and Biological Sciences Research Council (BBSRC) have discovered a new mechanism controlling ageing in white blood cells. The research, published in the September issue of the Journal of Immunology, opens up the possibility of
A Swedish hospital recently announced that a cancer patient was saved after doctors grew him a new windpipe in the lab using a synthetic structure and the man’s own stem cells. That might have sounded like science fiction just a
The NYT has a great article today about 61 year old Diana Nyad who is planning on swimming 60 hours straight with no sleep from Cuba to Key West. It’s a trek this record-holder attempted at age 28, but failed.
Here’s an interview I did with Rick Docksai, assistant editor for THE FUTURIST. We talk about longevity and my upcoming book, 100 Plus.
Dr. Atala of Wake Forest University is one of the leaders in the field of regenerative medicine — a true hero. Here’s a recent op-ed he wrote for CNN on the topic.
This is a super-interesting post about reactions to new technology over at the the WSJ. According to Intel’s Genevieve Bell, electricity was initially opposed because some people thought it would make women and children vulnerable in their homes at night
The headline of this USA Today story is somewhat misleading, since the trachea that was created using an artificial scaffold was made with the patient’s own cells. It’s a sort of artificial/biological mix of a trachea. In any case, the
Here is an article from Reuters reporting on Aubrey de Grey’s lecture at Britain’s Royal Institution academy of science.
From Nature News: Scientists have developed a gene-repair kit that treats the blood-clotting disorder haemophilia in mice. The technique replaces genes in targeted organs without removing cells from the body, simultaneously correcting multiple mutations. It broadens the range of diseases
From Science Daily: A yet unidentified component of coffee interacts with the beverage’s caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer’s disease. A new Alzheimer’s mouse study by researchers at the University of South
According to FDA Commissioner Margaret A. Hamburg: Our goal is to regulate these products using the best possible science. Understanding nanotechnology remains a top priority within the agency’s regulatory science initiative and, in doing so, we will be prepared to